Its not a medication, and its not approved for human or animal use outside of authorized studies 5-Amino-1MQ is a small-molecule research compound supplied for in-vitro investigation into metabolic and enzymatic signaling pathways, particularly through its activity as an inhibitor of nicotinamide N-methyltransferase (NNMT)
Injectable Vials (Reference) Counts assume a 5 mg vial reconstituted with 2 mL BAC water (2,500 mcg/mL) and a daily 500 mcg subcutaneous draw a common community pattern, not a clinically validated dose
You're not studying the effects of Retatrutide anymore
A reader who wants to evaluate the underlying papers can search PubMed for "GHK-Cu", "Thymosin beta 4 wound", "BPC-157 tendon" and "BPC-157 angiogenesis" to find the canonical entry points
As with any therapeutic compound, consultation with a healthcare provider knowledgeable about peptide therapy is recommended before beginning treatment
In addition, this technical note demonstrated the feasibility and efficacy of ultrasound-guided perineural injection